Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
62.6M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
2.05M
-
Shares change
-
-112K
-
Total reported value, excl. options
-
$6.62M
-
Value change
-
-$413K
-
Put/Call ratio
-
0.49
-
Number of buys
-
17
-
Number of sells
-
-15
-
Price
-
$3.23
Significant Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q1 2022
43 filings reported holding IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2022.
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.05M shares
of 62.6M outstanding shares and own 3.28% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (703K shares), TWO SIGMA ADVISERS, LP (247K shares), RICE HALL JAMES & ASSOCIATES, LLC (145K shares), GEODE CAPITAL MANAGEMENT, LLC (130K shares), Richmond Brothers, Inc. (125K shares), Ikarian Capital, LLC (124K shares), STATE STREET CORP (62.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (52.1K shares), TWO SIGMA INVESTMENTS, LP (51.7K shares), and Diametric Capital, LP (51.5K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.